| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biosensing Techniques | 13 | 2025 | 130 | 4.080 |
Why?
|
| Parents | 11 | 2025 | 359 | 2.360 |
Why?
|
| Adoption | 11 | 2018 | 15 | 2.170 |
Why?
|
| Nucleic Acid Amplification Techniques | 4 | 2024 | 40 | 1.940 |
Why?
|
| Hydrogels | 3 | 2024 | 55 | 1.770 |
Why?
|
| MicroRNAs | 5 | 2024 | 501 | 1.720 |
Why?
|
| Humans | 114 | 2026 | 42163 | 1.650 |
Why?
|
| Hawaii | 29 | 2026 | 2004 | 1.630 |
Why?
|
| Heart Failure | 3 | 2022 | 298 | 1.490 |
Why?
|
| Stomach Neoplasms | 3 | 2024 | 228 | 1.480 |
Why?
|
| Depression | 9 | 2025 | 837 | 1.300 |
Why?
|
| Eating | 3 | 2021 | 164 | 1.280 |
Why?
|
| Adult | 55 | 2026 | 13458 | 1.260 |
Why?
|
| Female | 75 | 2026 | 24018 | 1.250 |
Why?
|
| Health Status | 4 | 2022 | 432 | 1.240 |
Why?
|
| Mothers | 8 | 2024 | 212 | 1.200 |
Why?
|
| Exosomes | 4 | 2025 | 124 | 1.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2024 | 959 | 1.180 |
Why?
|
| Male | 64 | 2026 | 22779 | 1.180 |
Why?
|
| Oral Health | 2 | 2020 | 86 | 1.140 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 680 | 1.070 |
Why?
|
| Middle Aged | 41 | 2026 | 11819 | 1.050 |
Why?
|
| Civil Defense | 2 | 2024 | 16 | 1.040 |
Why?
|
| Burnout, Professional | 2 | 2026 | 25 | 1.010 |
Why?
|
| Psychometrics | 2 | 2026 | 350 | 1.010 |
Why?
|
| Students, Nursing | 3 | 2021 | 37 | 1.000 |
Why?
|
| Poverty | 5 | 2025 | 395 | 0.980 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 242 | 0.970 |
Why?
|
| Spectrum Analysis, Raman | 6 | 2025 | 94 | 0.960 |
Why?
|
| Nurse Practitioners | 1 | 2026 | 23 | 0.950 |
Why?
|
| Colorimetry | 2 | 2022 | 52 | 0.940 |
Why?
|
| Feeding Behavior | 2 | 2020 | 461 | 0.940 |
Why?
|
| Health Status Disparities | 3 | 2020 | 705 | 0.930 |
Why?
|
| Child | 19 | 2025 | 3381 | 0.900 |
Why?
|
| Diabetes Mellitus | 5 | 2021 | 532 | 0.900 |
Why?
|
| Cross-Sectional Studies | 19 | 2025 | 3077 | 0.890 |
Why?
|
| Osteoarthritis | 2 | 2021 | 25 | 0.870 |
Why?
|
| Education, Nursing, Baccalaureate | 2 | 2014 | 18 | 0.860 |
Why?
|
| Aged | 29 | 2025 | 7982 | 0.850 |
Why?
|
| Quality of Life | 2 | 2020 | 599 | 0.850 |
Why?
|
| United States | 21 | 2025 | 5072 | 0.830 |
Why?
|
| Aptamers, Nucleotide | 1 | 2024 | 51 | 0.820 |
Why?
|
| Social Identification | 1 | 2023 | 63 | 0.800 |
Why?
|
| African Swine Fever | 1 | 2022 | 2 | 0.790 |
Why?
|
| African Swine Fever Virus | 1 | 2022 | 3 | 0.790 |
Why?
|
| Hyperkalemia | 1 | 2022 | 13 | 0.790 |
Why?
|
| Liver Transplantation | 2 | 2015 | 37 | 0.770 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 188 | 0.760 |
Why?
|
| Social Support | 1 | 2025 | 438 | 0.740 |
Why?
|
| Biomedical Research | 2 | 2023 | 467 | 0.720 |
Why?
|
| Body Mass Index | 6 | 2019 | 916 | 0.700 |
Why?
|
| Adolescent | 20 | 2025 | 5950 | 0.690 |
Why?
|
| Mental Health Services | 2 | 2020 | 134 | 0.660 |
Why?
|
| Job Satisfaction | 2 | 2025 | 16 | 0.660 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2020 | 8 | 0.650 |
Why?
|
| Students | 3 | 2023 | 617 | 0.650 |
Why?
|
| Young Adult | 22 | 2025 | 4936 | 0.650 |
Why?
|
| Medicaid | 2 | 2018 | 138 | 0.650 |
Why?
|
| Emotions | 2 | 2023 | 251 | 0.640 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 121 | 0.640 |
Why?
|
| Stroke | 2 | 2021 | 348 | 0.630 |
Why?
|
| Absenteeism | 1 | 2019 | 14 | 0.610 |
Why?
|
| Cognition | 3 | 2023 | 458 | 0.610 |
Why?
|
| Prevalence | 7 | 2022 | 1597 | 0.600 |
Why?
|
| Aged, 80 and over | 14 | 2025 | 2803 | 0.580 |
Why?
|
| Papillomavirus Infections | 4 | 2024 | 363 | 0.570 |
Why?
|
| Papillomavirus Vaccines | 3 | 2025 | 168 | 0.550 |
Why?
|
| Exercise | 3 | 2020 | 674 | 0.550 |
Why?
|
| Hospital Mortality | 2 | 2018 | 206 | 0.540 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 309 | 0.530 |
Why?
|
| Referral and Consultation | 1 | 2018 | 141 | 0.530 |
Why?
|
| Integrative Medicine | 1 | 2016 | 8 | 0.520 |
Why?
|
| Patient Care Team | 4 | 2019 | 57 | 0.520 |
Why?
|
| Nutrition Surveys | 5 | 2025 | 263 | 0.510 |
Why?
|
| Reproducibility of Results | 8 | 2026 | 1058 | 0.510 |
Why?
|
| Curriculum | 3 | 2025 | 311 | 0.500 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2016 | 12 | 0.500 |
Why?
|
| Complementary Therapies | 1 | 2016 | 51 | 0.490 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2015 | 24 | 0.470 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2015 | 5 | 0.470 |
Why?
|
| Risk Adjustment | 1 | 2015 | 18 | 0.470 |
Why?
|
| Personality | 2 | 2012 | 55 | 0.460 |
Why?
|
| Hepatocytes | 1 | 2015 | 79 | 0.460 |
Why?
|
| Models, Theoretical | 1 | 2016 | 230 | 0.460 |
Why?
|
| Child, Preschool | 8 | 2024 | 1516 | 0.460 |
Why?
|
| Central Nervous System | 1 | 2016 | 150 | 0.460 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 94 | 0.450 |
Why?
|
| Hydrogen Sulfide | 1 | 2016 | 77 | 0.450 |
Why?
|
| Air Pollutants | 1 | 2016 | 127 | 0.440 |
Why?
|
| Empathy | 1 | 2014 | 31 | 0.440 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 972 | 0.440 |
Why?
|
| Residential Facilities | 1 | 2014 | 8 | 0.430 |
Why?
|
| Internship, Nonmedical | 1 | 2014 | 2 | 0.430 |
Why?
|
| Socioeconomic Factors | 9 | 2020 | 1221 | 0.430 |
Why?
|
| Environmental Exposure | 1 | 2016 | 247 | 0.420 |
Why?
|
| Nurses | 2 | 2025 | 55 | 0.410 |
Why?
|
| Long-Term Care | 1 | 2014 | 55 | 0.410 |
Why?
|
| Depressive Disorder | 2 | 2012 | 185 | 0.410 |
Why?
|
| Leadership | 1 | 2014 | 84 | 0.400 |
Why?
|
| Nanostructures | 2 | 2025 | 158 | 0.390 |
Why?
|
| Dementia | 1 | 2014 | 155 | 0.380 |
Why?
|
| Liver | 1 | 2015 | 503 | 0.380 |
Why?
|
| Mice | 10 | 2025 | 6490 | 0.370 |
Why?
|
| Hospitalization | 3 | 2022 | 482 | 0.370 |
Why?
|
| Nursing Staff, Hospital | 2 | 2025 | 19 | 0.350 |
Why?
|
| Energy Intake | 4 | 2020 | 162 | 0.350 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2010 | 23 | 0.340 |
Why?
|
| Retrospective Studies | 10 | 2022 | 2485 | 0.340 |
Why?
|
| Animals | 13 | 2025 | 16695 | 0.340 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2010 | 18 | 0.340 |
Why?
|
| Infant | 6 | 2024 | 1143 | 0.340 |
Why?
|
| Self Care | 3 | 2023 | 173 | 0.320 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2009 | 7 | 0.320 |
Why?
|
| Endoscopy | 1 | 2009 | 15 | 0.320 |
Why?
|
| Preoperative Care | 1 | 2009 | 31 | 0.320 |
Why?
|
| Healthcare Disparities | 5 | 2018 | 573 | 0.320 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 30 | 0.310 |
Why?
|
| Medicare | 4 | 2021 | 326 | 0.310 |
Why?
|
| Community Networks | 2 | 2020 | 106 | 0.300 |
Why?
|
| Risk Factors | 7 | 2021 | 3942 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 577 | 0.300 |
Why?
|
| Longevity | 2 | 2023 | 171 | 0.300 |
Why?
|
| Diet Surveys | 2 | 2020 | 97 | 0.290 |
Why?
|
| Neoplasms | 3 | 2025 | 1341 | 0.290 |
Why?
|
| Anal Canal | 2 | 2019 | 32 | 0.290 |
Why?
|
| Apoptosis | 2 | 2015 | 1541 | 0.290 |
Why?
|
| Longitudinal Studies | 5 | 2025 | 1020 | 0.290 |
Why?
|
| Intention | 3 | 2024 | 103 | 0.290 |
Why?
|
| Dental Care | 2 | 2020 | 41 | 0.280 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 428 | 0.280 |
Why?
|
| Physicians | 2 | 2020 | 180 | 0.280 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 471 | 0.270 |
Why?
|
| Factor Analysis, Statistical | 2 | 2026 | 157 | 0.270 |
Why?
|
| Parenting | 3 | 2017 | 135 | 0.260 |
Why?
|
| Mutation | 2 | 2017 | 1169 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 727 | 0.260 |
Why?
|
| Chronic Disease | 5 | 2022 | 541 | 0.260 |
Why?
|
| Communicable Diseases | 2 | 2025 | 47 | 0.260 |
Why?
|
| Needs Assessment | 2 | 2019 | 180 | 0.250 |
Why?
|
| Resuscitation | 2 | 2016 | 22 | 0.250 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 1 | 2025 | 1 | 0.240 |
Why?
|
| Fathers | 2 | 2024 | 35 | 0.240 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2019 | 280 | 0.240 |
Why?
|
| Health Services Research | 2 | 2018 | 161 | 0.240 |
Why?
|
| Thyroid Gland | 1 | 2025 | 23 | 0.240 |
Why?
|
| Dietary Proteins | 4 | 2017 | 35 | 0.240 |
Why?
|
| Psychological Tests | 1 | 2026 | 56 | 0.240 |
Why?
|
| Cultural Competency | 2 | 2024 | 137 | 0.240 |
Why?
|
| Interprofessional Relations | 2 | 2016 | 56 | 0.240 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 35 | 0.240 |
Why?
|
| Logistic Models | 3 | 2024 | 1001 | 0.240 |
Why?
|
| Immunization Schedule | 1 | 2025 | 9 | 0.240 |
Why?
|
| Membrane Fusion | 1 | 2025 | 12 | 0.240 |
Why?
|
| Mass Screening | 4 | 2023 | 531 | 0.240 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2025 | 15 | 0.240 |
Why?
|
| Personal Satisfaction | 2 | 2018 | 74 | 0.240 |
Why?
|
| Biomimetic Materials | 1 | 2025 | 24 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 22 | 0.230 |
Why?
|
| Influenza A virus | 1 | 2025 | 31 | 0.230 |
Why?
|
| Spouses | 2 | 2018 | 38 | 0.230 |
Why?
|
| School Nursing | 1 | 2025 | 12 | 0.220 |
Why?
|
| Vaccination | 5 | 2025 | 332 | 0.220 |
Why?
|
| Influenza, Human | 1 | 2025 | 90 | 0.220 |
Why?
|
| Sodium, Dietary | 2 | 2021 | 22 | 0.210 |
Why?
|
| Food Microbiology | 1 | 2024 | 38 | 0.210 |
Why?
|
| Limit of Detection | 1 | 2024 | 82 | 0.210 |
Why?
|
| Prenatal Care | 1 | 2024 | 82 | 0.210 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2023 | 10 | 0.210 |
Why?
|
| Indoles | 1 | 2025 | 178 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2023 | 26 | 0.210 |
Why?
|
| Health | 1 | 2023 | 30 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2025 | 189 | 0.200 |
Why?
|
| Clinical Competence | 3 | 2025 | 154 | 0.200 |
Why?
|
| Data Mining | 1 | 2023 | 30 | 0.200 |
Why?
|
| Pain, Postoperative | 2 | 2014 | 28 | 0.200 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 222 | 0.200 |
Why?
|
| Overweight | 3 | 2016 | 248 | 0.200 |
Why?
|
| Postoperative Complications | 2 | 2018 | 253 | 0.200 |
Why?
|
| Biogenic Amines | 1 | 2022 | 13 | 0.200 |
Why?
|
| Urease | 1 | 2022 | 16 | 0.200 |
Why?
|
| Receptor, erbB-2 | 1 | 2024 | 149 | 0.200 |
Why?
|
| Phosphoproteins | 1 | 2024 | 201 | 0.190 |
Why?
|
| Alginates | 1 | 2022 | 19 | 0.190 |
Why?
|
| Metal Nanoparticles | 2 | 2025 | 227 | 0.190 |
Why?
|
| Meat | 1 | 2022 | 46 | 0.190 |
Why?
|
| Culture | 1 | 2023 | 172 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2019 | 641 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 206 | 0.190 |
Why?
|
| Social Isolation | 1 | 2022 | 34 | 0.190 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 26 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2023 | 336 | 0.190 |
Why?
|
| Research Personnel | 1 | 2023 | 191 | 0.190 |
Why?
|
| Inpatients | 1 | 2022 | 78 | 0.190 |
Why?
|
| Early Diagnosis | 1 | 2022 | 69 | 0.190 |
Why?
|
| Swine | 1 | 2022 | 205 | 0.190 |
Why?
|
| Ambulatory Care | 1 | 2022 | 81 | 0.180 |
Why?
|
| Mother-Child Relations | 2 | 2012 | 61 | 0.180 |
Why?
|
| Patient Participation | 1 | 2022 | 87 | 0.180 |
Why?
|
| Diet | 3 | 2022 | 810 | 0.180 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 30 | 0.180 |
Why?
|
| Delirium | 2 | 2018 | 11 | 0.180 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 43 | 0.180 |
Why?
|
| Age Factors | 4 | 2025 | 1139 | 0.170 |
Why?
|
| Fruit | 2 | 2020 | 178 | 0.170 |
Why?
|
| Family Characteristics | 2 | 2019 | 124 | 0.170 |
Why?
|
| Health Behavior | 2 | 2018 | 568 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 46 | 0.170 |
Why?
|
| Genotype | 4 | 2023 | 796 | 0.170 |
Why?
|
| Nutrition Policy | 1 | 2021 | 64 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 53 | 0.170 |
Why?
|
| Proteomics | 1 | 2023 | 363 | 0.170 |
Why?
|
| Health Education, Dental | 1 | 2020 | 5 | 0.170 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2020 | 77 | 0.160 |
Why?
|
| Patient Readmission | 1 | 2022 | 120 | 0.160 |
Why?
|
| Diet Records | 2 | 2018 | 58 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 415 | 0.160 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 65 | 0.160 |
Why?
|
| Oseltamivir | 1 | 2019 | 9 | 0.160 |
Why?
|
| Body Fluids | 1 | 2019 | 18 | 0.160 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 22 | 0.160 |
Why?
|
| Pregnancy | 6 | 2024 | 1737 | 0.160 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 22 | 0.150 |
Why?
|
| Drug Resistance, Viral | 1 | 2019 | 67 | 0.150 |
Why?
|
| Managed Care Programs | 1 | 2019 | 39 | 0.150 |
Why?
|
| Obesity | 2 | 2025 | 1131 | 0.150 |
Why?
|
| Parent-Child Relations | 2 | 2017 | 125 | 0.150 |
Why?
|
| Trauma Centers | 2 | 2016 | 92 | 0.150 |
Why?
|
| Public Assistance | 1 | 2019 | 26 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 350 | 0.150 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 4 | 0.150 |
Why?
|
| Saliva | 1 | 2019 | 115 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2018 | 37 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2020 | 428 | 0.140 |
Why?
|
| Preventive Dentistry | 1 | 2018 | 3 | 0.140 |
Why?
|
| Leukocytes | 1 | 2018 | 79 | 0.140 |
Why?
|
| Precancerous Conditions | 1 | 2019 | 83 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 85 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 268 | 0.140 |
Why?
|
| Oral Hygiene | 1 | 2018 | 23 | 0.140 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 25 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2018 | 44 | 0.140 |
Why?
|
| Family | 1 | 2019 | 192 | 0.140 |
Why?
|
| Doxycycline | 1 | 2017 | 32 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2018 | 845 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2018 | 82 | 0.140 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 6 | 0.140 |
Why?
|
| Fee-for-Service Plans | 1 | 2017 | 21 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2017 | 21 | 0.130 |
Why?
|
| Breast Feeding | 1 | 2019 | 123 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 25 | 0.130 |
Why?
|
| Dental Caries | 1 | 2018 | 55 | 0.130 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 196 | 0.130 |
Why?
|
| Postpartum Hemorrhage | 1 | 2017 | 19 | 0.130 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 216 | 0.130 |
Why?
|
| Communication Barriers | 1 | 2017 | 60 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 526 | 0.130 |
Why?
|
| Schools | 1 | 2019 | 283 | 0.130 |
Why?
|
| Self Efficacy | 2 | 2025 | 211 | 0.130 |
Why?
|
| Health Services for the Aged | 1 | 2016 | 26 | 0.130 |
Why?
|
| Microcephaly | 1 | 2016 | 21 | 0.130 |
Why?
|
| Food Preferences | 1 | 2017 | 73 | 0.130 |
Why?
|
| Stomatognathic Diseases | 1 | 2016 | 3 | 0.130 |
Why?
|
| Obstetric Labor, Premature | 1 | 2016 | 9 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2019 | 733 | 0.130 |
Why?
|
| Sleep Stages | 1 | 2016 | 6 | 0.130 |
Why?
|
| Body Weight | 1 | 2018 | 428 | 0.130 |
Why?
|
| Incidence | 3 | 2019 | 1054 | 0.130 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1051 | 0.130 |
Why?
|
| Nanocapsules | 1 | 2016 | 19 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 37 | 0.120 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 35 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 164 | 0.120 |
Why?
|
| Critical Care | 1 | 2016 | 48 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 29 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 61 | 0.120 |
Why?
|
| Patient-Centered Care | 1 | 2016 | 73 | 0.120 |
Why?
|
| Primary Health Care | 1 | 2019 | 362 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 106 | 0.120 |
Why?
|
| Semustine | 1 | 2015 | 1 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2016 | 25 | 0.120 |
Why?
|
| Heterozygote | 2 | 2018 | 107 | 0.120 |
Why?
|
| Mitomycin | 1 | 2015 | 13 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2017 | 225 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2018 | 196 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 270 | 0.120 |
Why?
|
| Tacrolimus | 1 | 2015 | 15 | 0.120 |
Why?
|
| Professional Role | 1 | 2015 | 40 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2015 | 36 | 0.120 |
Why?
|
| DNA | 3 | 2023 | 594 | 0.120 |
Why?
|
| Disease Progression | 1 | 2018 | 661 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 68 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2015 | 46 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 94 | 0.120 |
Why?
|
| Exercise Therapy | 1 | 2016 | 83 | 0.120 |
Why?
|
| Electroencephalography | 1 | 2016 | 135 | 0.120 |
Why?
|
| Reference Values | 1 | 2015 | 207 | 0.120 |
Why?
|
| Sirolimus | 1 | 2015 | 70 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2018 | 1574 | 0.110 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 64 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 233 | 0.110 |
Why?
|
| Asthma | 1 | 2019 | 410 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2015 | 226 | 0.110 |
Why?
|
| Confusion | 1 | 2014 | 5 | 0.110 |
Why?
|
| Arthroplasty | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 250 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 295 | 0.110 |
Why?
|
| Nursing Evaluation Research | 1 | 2014 | 11 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 207 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2014 | 100 | 0.110 |
Why?
|
| Nursing Education Research | 1 | 2014 | 14 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 61 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 410 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 860 | 0.110 |
Why?
|
| Object Attachment | 1 | 2014 | 27 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 209 | 0.100 |
Why?
|
| Family Health | 1 | 2013 | 56 | 0.100 |
Why?
|
| Eosinophils | 1 | 2013 | 22 | 0.100 |
Why?
|
| Blood Glucose | 2 | 2016 | 386 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 1804 | 0.100 |
Why?
|
| Immunoassay | 2 | 2024 | 69 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 1679 | 0.100 |
Why?
|
| Health Promotion | 1 | 2019 | 691 | 0.100 |
Why?
|
| Leucine | 1 | 2012 | 30 | 0.100 |
Why?
|
| Milk Proteins | 1 | 2012 | 29 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 502 | 0.090 |
Why?
|
| Microfluidics | 2 | 2023 | 45 | 0.090 |
Why?
|
| Comorbidity | 3 | 2020 | 725 | 0.090 |
Why?
|
| Cell Survival | 1 | 2015 | 934 | 0.090 |
Why?
|
| Gold | 2 | 2025 | 153 | 0.090 |
Why?
|
| Stem Cells | 1 | 2013 | 151 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 245 | 0.090 |
Why?
|
| Sex Factors | 2 | 2012 | 1008 | 0.090 |
Why?
|
| Thyrotropin | 2 | 2025 | 23 | 0.090 |
Why?
|
| Body Composition | 1 | 2012 | 160 | 0.090 |
Why?
|
| Nitrogen | 1 | 2012 | 83 | 0.090 |
Why?
|
| Nutritional Requirements | 1 | 2011 | 33 | 0.090 |
Why?
|
| Appetite Regulation | 1 | 2010 | 9 | 0.090 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2010 | 32 | 0.090 |
Why?
|
| Bacteria | 2 | 2024 | 285 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 97 | 0.080 |
Why?
|
| Education, Nursing, Continuing | 2 | 2025 | 14 | 0.080 |
Why?
|
| Resistance Training | 1 | 2010 | 20 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 744 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 92 | 0.080 |
Why?
|
| Amino Acids | 1 | 2011 | 150 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 137 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2010 | 117 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2023 | 232 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2016 | 1586 | 0.080 |
Why?
|
| Ligation | 1 | 2009 | 12 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 2010 | 70 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 26 | 0.080 |
Why?
|
| Adenoma | 1 | 2010 | 94 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2009 | 39 | 0.080 |
Why?
|
| Mental Health | 1 | 2013 | 363 | 0.080 |
Why?
|
| Insulin | 1 | 2011 | 255 | 0.080 |
Why?
|
| Insurance Claim Review | 2 | 2020 | 35 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 454 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 206 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 330 | 0.070 |
Why?
|
| Universities | 2 | 2023 | 539 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 287 | 0.070 |
Why?
|
| Brain | 1 | 2016 | 1452 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2021 | 633 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 158 | 0.070 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2021 | 36 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 557 | 0.070 |
Why?
|
| Motivation | 1 | 2011 | 492 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 211 | 0.070 |
Why?
|
| Bacterial Proteins | 2 | 2023 | 580 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2018 | 587 | 0.060 |
Why?
|
| Child Behavior | 2 | 2017 | 81 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2025 | 35 | 0.060 |
Why?
|
| British Columbia | 1 | 2024 | 19 | 0.060 |
Why?
|
| Dogs | 1 | 2025 | 201 | 0.060 |
Why?
|
| Sulfides | 1 | 2025 | 77 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 305 | 0.060 |
Why?
|
| Liposomes | 1 | 2025 | 130 | 0.050 |
Why?
|
| Workplace | 1 | 2025 | 86 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2598 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 2024 | 24 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 2 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2023 | 34 | 0.050 |
Why?
|
| Klebsiella pneumoniae | 1 | 2023 | 26 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 339 | 0.050 |
Why?
|
| Emergencies | 1 | 2023 | 32 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 140 | 0.050 |
Why?
|
| Virus Replication | 1 | 2025 | 318 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2023 | 61 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2023 | 54 | 0.050 |
Why?
|
| Phenotype | 1 | 2025 | 774 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 59 | 0.050 |
Why?
|
| Guam | 1 | 2022 | 83 | 0.050 |
Why?
|
| Gender Identity | 1 | 2023 | 117 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2016 | 208 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 136 | 0.050 |
Why?
|
| Diet, Mediterranean | 1 | 2022 | 37 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2016 | 960 | 0.050 |
Why?
|
| Cell Separation | 1 | 2021 | 94 | 0.040 |
Why?
|
| Seafood | 1 | 2021 | 24 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 249 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 37 | 0.040 |
Why?
|
| Attitude | 1 | 2021 | 108 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 266 | 0.040 |
Why?
|
| Nose | 1 | 2019 | 12 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1554 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 157 | 0.040 |
Why?
|
| Endocrine System Diseases | 1 | 2018 | 16 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 176 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2017 | 14 | 0.040 |
Why?
|
| Elastin | 1 | 2017 | 40 | 0.030 |
Why?
|
| Japan | 1 | 2018 | 348 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 38 | 0.030 |
Why?
|
| Income | 1 | 2019 | 160 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 1729 | 0.030 |
Why?
|
| Matrix Metalloproteinases | 1 | 2017 | 49 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 87 | 0.030 |
Why?
|
| Isoniazid | 1 | 2017 | 6 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2018 | 62 | 0.030 |
Why?
|
| Cameroon | 1 | 2017 | 35 | 0.030 |
Why?
|
| Rifampin | 1 | 2017 | 8 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1265 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 352 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2019 | 245 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 311 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2020 | 359 | 0.030 |
Why?
|
| Philippines | 1 | 2017 | 80 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 362 | 0.030 |
Why?
|
| Garbage | 1 | 2017 | 2 | 0.030 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 33 | 0.030 |
Why?
|
| Blood Banks | 1 | 2016 | 10 | 0.030 |
Why?
|
| Home Care Services | 1 | 2017 | 37 | 0.030 |
Why?
|
| Spirituality | 1 | 2017 | 52 | 0.030 |
Why?
|
| Dairy Products | 1 | 2017 | 34 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2017 | 79 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 167 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2017 | 48 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 87 | 0.030 |
Why?
|
| Polysomnography | 1 | 2016 | 41 | 0.030 |
Why?
|
| Professional Competence | 1 | 2016 | 42 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 34 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 18 | 0.030 |
Why?
|
| Critical Illness | 1 | 2016 | 46 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 358 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 71 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 143 | 0.030 |
Why?
|
| Arousal | 1 | 2016 | 95 | 0.030 |
Why?
|
| Minority Health | 1 | 2016 | 96 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 67 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2111 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 76 | 0.030 |
Why?
|
| Vegetables | 1 | 2017 | 145 | 0.030 |
Why?
|
| Video Recording | 1 | 2015 | 40 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 602 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 253 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 174 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 238 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 850 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 456 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 508 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 438 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 686 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 108 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 141 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2019 | 1376 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 154 | 0.030 |
Why?
|
| Decision Making | 1 | 2016 | 242 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2016 | 199 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2014 | 193 | 0.030 |
Why?
|
| Child Welfare | 1 | 2014 | 49 | 0.030 |
Why?
|
| Cell Death | 1 | 2014 | 277 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 462 | 0.030 |
Why?
|
| Esophagitis | 1 | 2013 | 7 | 0.030 |
Why?
|
| HIV-1 | 1 | 2019 | 747 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2018 | 483 | 0.020 |
Why?
|
| Appetite | 1 | 2012 | 21 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2012 | 82 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 233 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2011 | 13 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 973 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 1848 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 649 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 729 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 181 | 0.020 |
Why?
|
| Hunger | 1 | 2010 | 12 | 0.020 |
Why?
|
| Beverages | 1 | 2011 | 65 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 698 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1416 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 112 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 111 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2010 | 93 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 363 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 1617 | 0.020 |
Why?
|